Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience

被引：0
|
作者：
Kim, Hong Joo [1 ]
Kim, Nam Hee [1 ]
机构：
[1] Sungkyunkwan Univ, Dept Internal Med, Kangbuk Samsung Hosp, Seoul, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
721
引用
收藏
页码：370 / 371
页数：2
相关论文
共 50 条
  • [31] Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir
    Kuo, Ming-Te
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Tsai, Kai-Lung
    Chen, Chien-Hung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (02) : 218 - 228
  • [32] ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE
    Baran, B.
    Soyer, O. M.
    Ormeci, A. C.
    Gokturk, S.
    Evirgen, S.
    Akyuz, F.
    Karaca, C.
    Demir, K.
    Gulluoglu, M.
    Onel, D.
    Badur, S.
    Besisik, F.
    Kaymakoglu, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S424 - S424
  • [33] Entecavir in the treatment of chronic hepatitis B: multicenter randomized trials and real clinical practice
    Abdurakhmanov, D. T.
    Otrashevskaya, A. V.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (11) : 100 - +
  • [34] A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice
    Tsai, Ming-Chao
    Lee, Chuan-Mo
    Chiu, King-Wah
    Hung, Chao-Hung
    Tung, Wei-Chih
    Chen, Chien-Hung
    Tseng, Po-Lin
    Chang, Kuo-Chin
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Yen, Yi-Hao
    Hu, Tsung-Hui
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (03) : 696 - 699
  • [35] Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis
    Moschouri, Eleni
    Salemme, Gloria
    Baserga, Adriana
    Cerny, Andreas
    Deibel, Ansgar
    Meier, Marie-Anne
    Bernsmeier, Christine
    Ongaro, Marie
    Negro, Francesco
    Grosjean, Marielle
    Clerc, Olivier
    Kuenzler-Heule, Patrizia
    Semela, David
    Hobi, Gabriel
    Stickel, Felix
    Mathieu, Adeline
    Mdawar-Bailly, Elise
    Faouzi, Mohamed
    Moradpour, Darius
    Fragaa, Montserrat
    SWISS MEDICAL WEEKLY, 2024, 154
  • [36] PERSISTENCE TO ENTECAVIR TREATMENT FOR CHRONIC HEPATITIS B IN A REAL-LIFE SETTING: 2 YEAR RESULTS OF A GERMAN PROSPECTIVE MULTICENTRE OBSERVATIONAL STUDY
    Petersen, J.
    Wilke, T.
    Mauss, S.
    Heyne, R.
    Herold, C.
    Wiese, M.
    Boeker, K.
    Pichl, T.
    Meier, A.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S593 - S594
  • [37] Real-world experience fromtenofovir alafenamide use in chronic hepatitis B: an Hellenic multicenter real-life clinical study (HERACLIS-TAF)
    Papatheodoridis, George
    Mimidis, Konstantinos
    Manolakopoulos, Spilios
    Gatselis, Nikolaos
    Goulis, Ioannis
    Andreas, Kapatais
    Manesis, Emmanouil
    Vasileiadis, Themistoklis
    Triantos, Christos
    Samonakis, Demetrious N.
    Sevastianos, Vasilis
    Karapatanis, Stylianos
    Elefsiniotis, Ioannis
    Deutsch, Melanie
    Mylopoulou, Theodora
    Papatheodoridi, Margarita
    Kranidioti, Hariklia
    Agorastou, Polyxeni
    Karaoulani, Theofanie
    Kyriazidou, Anastasia
    Zisimopoulos, Konstanitnos
    Dalekos, George
    JOURNAL OF HEPATOLOGY, 2020, 73 : S865 - S866
  • [38] Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
    Sarrecchia, C.
    Svicher, V.
    Volpi, A.
    Salpini, R.
    Ceccarelli, L.
    Sordillo, P.
    Bertoli, A.
    Perno, C. F.
    Andreoni, M.
    INFECTION, 2011, 39 (04) : 367 - 370
  • [39] Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
    C. Sarrecchia
    V. Svicher
    A. Volpi
    R. Salpini
    L. Ceccarelli
    P. Sordillo
    A. Bertoli
    C. F. Perno
    M. Andreoni
    Infection, 2011, 39 : 367 - 370
  • [40] Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience
    Tsai, M. -C.
    Chen, C. -H.
    Tseng, P. -L.
    Hung, C. -H.
    Chiu, K. -W.
    Wang, J. -H.
    Lu, S. -N.
    Lee, C. -M.
    Chang, K. -C.
    Yen, Y. -H.
    Lin, M. -T.
    Chou, Y. -P.
    Hu, T. -H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (01) : 95.e1 - 95.e7
12345